Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic propertiesElectronic supplementary information (ESI) available. See DOI: 10.1039/c5md00166h
A series of alkyl/arylsulfonamide derivatives of (aryloxy)ethylpiperidines as highly potent 5-HT 7 receptor antagonists has been developed through structure-based design on the previously identified compound PZ-766. This resulted in highly potent antagonist 10 (3-fluoro- N -(1-{2-[(propan-2-yl)pheno...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Journal Article |
Language | English |
Published |
08.07.2015
|
Online Access | Get full text |
Cover
Loading…
Summary: | A series of alkyl/arylsulfonamide derivatives of (aryloxy)ethylpiperidines as highly potent 5-HT
7
receptor antagonists has been developed through structure-based design on the previously identified compound PZ-766. This resulted in highly potent antagonist
10
(3-fluoro-
N
-(1-{2-[(propan-2-yl)phenoxy]ethyl}piperidin-4-yl)-benzenesulfonamide) which was more active
in vivo
than PZ-766 and SB-269970 in forced swim test in mice (MED = 2.5 mg kg
−1
), and displayed comparable effects to SB-269970 in four-plate test in mice (MED = 1.25 mg kg
−1
) and novel object recognition test in rats (MED = 1 mg kg
−1
). The results highlight the antidepressant, anxiolytic and pro-cognitive potential of the arylsulfonamide derivatives of (aryloxy)ethylpiperidines with 5-HT
7
receptor antagonist properties and warrant further studies to explore their therapeutic potential for the treatment of CNS disorders.
A novel series of potent 5-HT
7
receptor antagonist and their antidepressant, anxiolytic and pro-cognitive properties is described. |
---|---|
Bibliography: | 10.1039/c5md00166h Electronic supplementary information (ESI) available. See DOI |
ISSN: | 2040-2503 2040-2511 |
DOI: | 10.1039/c5md00166h |